Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Tularemia Natural History of Francisella tularensis History ● Leviticus 11:6-7 – ● Wherry WB, Lamb BH. Infection of man with Bacterium tularense. J Infect Dis 1914l 15:331-40 – ● But you shall not eat any of the following that only chew the cud or only have hoofs ... the hare, which indeed chews the cud, but does not have hoofs and is therefore unclean for you first description of human tularemia with culture of causative organism Francis E. A summary of the present knowledge of tularemia. Medicine (Baltimore) 1928;7:411-32. – clinical and epidemiological study of >600 human cases Pathogen – Francisella tularensis ● Gram negative non-motile non-sporulating cocco-bacillus ● Reservoir unknown – ● Infects small mammals – ● ground squirrels, rabbits, hares, voles, muskrats, water rats and other rodents Arthropod vectors – ● free living protozoa? ticks, biting flies, mosquitoes Uncommon zoonosis – 125 cases/year in USA – farmers, hunters, walkers, forest workers – kills less than 50 people a year worldwide Bioterrorism (1) ● Category A agents – – bacterial ● Francisella tularensis (tularemia) ● Bacillus anthracis (anthrax) ● Yersinia pestis (plague) ● Clostridium botulinum (botulism) viral ● Variola major (smallpox) ● Viral hemorrhagic fever (ebola, marburg, lassa, argentine) Bioterrorism (2) ● ● ● Tested by Japan in WWII as potential bioweapon Weaponised and stockpiled by USA and USSR during Cold War Epidemics (probably natural causes) – Battle of Stalingrad 1942-1943 – Kosovo 1999 (327 cases, no fatalities) – Recurrent outbreaks on Martha's vineyard (cause unknown) Microbiology Subspecies ● ● F. tularensis subsp. tularensis (Type A) – LD50 ~ 1 (mice) – LD50 < 102 (humans) F. tularensis subsp. holarctica (Type B) – LD50 > 106 (rabbits) ● F. tularensis subsp. mediasiatica ● F. tularensis subsp. novicida Taxonomy Transmission ● Highly infectious – ● ● inhalation of 10 bacteria can cause disease Avenues – ingestion (water and food) – inhalation – direct contact – arthropod intermediates – animal bites No person to person spread Vectors in America Biting fly Utah, Nevada, California Tick East of Rocky Mountains Disease Forms ● Ulceroglandular (<5% mortality untreated) ● Oculoglandular ● Typhoidal syndrome (30-60% mortality untreated) ● Oropharyngeal ● Gastrointestinal ● Secondary pneumonia ● Primary inhalational pneumonia Clinical Disease ● ● Ulceroglandular – Incubation period 3-6 days – Sudden onset flu like symptoms – Ulcer at site of infection – Enlargement of draining nodes Typhoidal syndrome – ● Oropharyngeal – ● sore throat, enlarged tonsils, yellow-white pseudomembrane Gastrointestinal – ● septicemia without ulcer or lymphadenopathy persistent diarrhea, bowel ulceration -> acute fatal disease Pneumonia Ulceroglandular Tularemia Diagnosis ● Culture – ● high risk to laboratory personnel Non-culture methods – – Serology ● ELISA ● micro-agglutination ● Western blot ● flow cytometry ● indirect immunofluorescence PCR Treatment ● ● Recommended – Streptomycin – Gentamicin Oral medication – Fluroquinolones (Ciprofloxacin) ● Mortality -> 0 ● Reduce debilitating features of disease Vaccines ● ● ● Live vaccines – F. tularensis LVS – water rat -> USSR -> USAMRIID (1956) – Use halted by FDA 2001 Problems – protects against inhalational but not cutaneous disease – protective response not well understood – basis of attenuation not known – potential for reversion No effective killed bacterial or subtype vaccine Model Organism ● Animal models available ● Cell culture models available ● Live vaccine strain available ● Grows rapidly in vivo and in vitro ● Genome sequencing in progress ● Public health interest Host-pathogen (0) Intracellular living 1. Cell Entry 2. Replication ●cytoplasmic ●phagosomal ●phagolysosomal 3. Cell Exit Host-Pathogen (1) ● Obligate intracellular pathogen – ● ● ● macrophages, hepatocytes, endothelial cells, fibroblasts Entry pathway unknown – no respiratory burst – complement/complement receptor dependent? Intracellular residence – first 4 hours -> non-acidified phagosome – after 8 hours -> cytoplasm Doubling time in macrophages is 4-6 hours Host-Pathogen (2) ● Inhibits NF-kB and MAPK activation by TLR ligation ● Evade phagosome-lysosome fusion ● No evidence for secreted toxins ● Induces apoptosis in murine macrophages Virulence Factors ● Atypical LPS – ● Capsule – ● ● prevents serum-mediated lysis Pili – ● elicits 1000-fold less TNF and IL-1 than E. coli adherence, cell-cell interactions, biofilm formation Proteins – pathogenicity island (FPI) recently discovered – mglA, mglB transcriptional regulator – mglA positively regulates pdpA, pdpD, iglA, iglC, and iglD genes – iglC (23 kD protein) disrupts TLR signaling Other components – 'phosphoantigens' expand gd-T cells (significance unknown) Francisella Pathogenecity Island (FPI) 1. 30 kb cluster of genes encoding virulence factors 2. flanked by transposable elements 3. G+C content significantly different from rest of chromosome Immunology (1) ● ● ● Early (<3 days) response is T cell independent – infected macrophages -> TNF-a – TNF-a -> NK cells -> IFN-g – IFN-g -> infected macrophage -> NO Late (>3 days) and secondary response is T cell dependent – Th1 response – CD4+, CD8+ and Thy1+ CD4-CD8- T cells cells important – IFN-g, TNF-a, RNS, ROS – Role of perforin, Fas-FasL cell killing unknown Others – gd-T cells expanded – Antibodies probably minor role – Neutrophils can phagocytose opsonized bacteria but poor killing Immunology (2) ● Infection confers long-lasting immunity – may be partial – ● ● Edward Francis infected at least 3 times Each immune individual recognises a mosaic of antigens No immunodominant antigens identified – Orchestration of the protective immune response to intracellular bacteria: Francisella tularensis as a model organism. FEMS Immunol Med Microb, 1996, 13:221-225 Genome ● ● 1 partial annotation published – Preliminary analysis and annotation of the partial genome sequence of Francisella tularensis strain Schu 4. J Appl Microbiol. 2001 Oct;91(4):61420 – Predicted ORFs with no match in GenBank much higher than other microbial genomes – No matches with known virulence genes in other pathogens 2 preliminary genome sequences completed – http://bbrp.llnl.gov/bbrp/html/microbe.html (Lawrence Livermore National Laboratory) – http://artedi.ebc.uu.se/Projects/Francisella/ (Uppsala University) Transcriptome ● ● Samrakandi MM et al, Genome diversity among regional populations of Francisella tularensis subspecies tularensis and Francisella tularensis subspecies holarctica isolated from the US, FEMS Microbiol Lett. 2004 Aug 1;237(1):9-17. Broekhuijsen M et al, Genome-wide DNA microarray analysis of Francisella tularensis strains demonstrates extensive genetic conservation within the species but identifies regions that are unique to the highly virulent F. tularensis subsp. tularensis, J Clin Microbiol. 2003 Jul;41(7):2924-31. Proteome ● ● Papers – Hubalek M et al, Proteomics. 2004 Oct;4(10):3048-60. – Hubalek M et al, J Chromatogr B Analyt Technol Biomed Life Sci. 2003 Apr 5;787(1):149-77. – Havlasova J et al, Proteomics. 2002 Jul;2(7):857-67. – Kovarova H et al, Proteomics. 2002 Jan;2(1):85-93. – Hernychova L et al, Proteomics. 2001 Apr;1(4):508-15. 2D PAGE Databases – ● http://web.mpiib-berlin.mpg.de/cgi-bin/pdbs/2d-page/extern/index.cgi 3D protein structure – http://pat.sdsc.edu/perl/browser.pl?tax=Francisella%20tularensis&tid=263 References ● J Infect Dis, 2004, 189:1317-1331 ● Clin Microb Rev, 2002, 15:631-646 ● Trends Microb, 2003, 11:118-123 ● Curr Opin Microb, 2003, 6:66-71 ● Lancet, 2000, 356:1179-1182 ● Infect Immun, 2004 72:3204-3217 ● J Bacteriol, 2004,186:6430-6436